Antibody Binding Sites as Therapeutics: From scFv to VHH and VNAR

Ho describes different approaches for therapeutic antibody discovery. He then introduces the concept of antibody binding site as therapeutics and takes a deep dive into the utility of single-chain variable fragment (scFv) and single domain antibodies in therapeutics.

• #science_technology
• #agm_day_2